Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium

Area of Science:

• Microbiology
• Cancer Biology
• Molecular Biology

Background:

• Salmonella enterica serovar Typhimurium (S. typhimurium) preferentially targets tumor sites and can inhibit cancer growth.
• P-glycoprotein (P-gp) is a key transporter involved in multidrug resistance (MDR) in cancer, effluxing chemotherapeutic drugs.
• Understanding microbial interactions with host cells is crucial for both infectious disease and cancer therapy.

Purpose of the Study:

• To investigate the effect of S. typhimurium infection on P-glycoprotein (P-gp) function and expression in human intestinal cancer cells.
• To determine if S. typhimurium can modulate the drug efflux capabilities mediated by P-gp.
• To explore the role of P-gp in the interaction between S. typhimurium and intestinal cancer cells.

Main Methods:

• In vitro infection model using polarized human intestinal cancer cell lines and S. typhimurium.
• Measurement of intracellular accumulation of P-gp substrates to assess efflux function.
• Analysis of P-gp expression levels post-infection.
• Experimental manipulation of MDR1 gene expression using small interfering RNAs (siRNAs).

Main Results:

• S. typhimurium infection leads to functional downregulation of P-gp efflux activity in cancer cells.
• Bacterial infection results in increased intracellular accumulation of P-gp substrates.
• Posttranscriptional downregulation of P-gp expression was observed following S. typhimurium infection.
• Cancer cells with reduced P-gp expression (MDR1 knockdown) were more susceptible to S. typhimurium infection.
• Conversely, S. typhimurium invasion was reduced in cells overexpressing MDR1.

Conclusions:

• S. typhimurium actively downregulates P-gp function and expression in intestinal cancer cells.
• This modulation by S. typhimurium has significant implications for reversing cancer drug resistance.
• P-gp plays a novel role in maintaining gastrointestinal homeostasis during bacterial infection.
• The findings suggest potential therapeutic strategies targeting P-gp for cancer treatment and offer insights into host-microbe interactions.